By contrast, CXCL1, CXCL2, CCL2 and TGFB2 with defined pro-tumorigenic roles are more highly expressed by EA1 tumor cells at baseline and may antagonize anti-tumorigenic effects of CD8+ T cells that do infiltrate this model. The gene discussed is TGFB2; the disease is neoplasm.